Lv1
38 积分 2023-10-13 加入
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
4小时前
已完结
DOD ‐ SSR : An Adaptive Seamless Phase II / III Design With Dose Optimization Decision and Sample Size Re‐estimation
19天前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
28天前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
28天前
已完结
Sirolimus for Venous Malformations: A Systematic Review of Efficacy and Safety
30天前
已关闭
Sirolimus for Venous Malformations: A Systematic Review of Efficacy and Safety
30天前
已关闭
Sirolimus for Venous Malformations: A Systematic Review of Efficacy and Safety
30天前
已关闭
Activity of a TIE2 inhibitor (rebastinib) in a patient with a life‐threatening cervicofacial venous malformation
30天前
已完结
Alpelisib for TEK- and PIK3CA-Related Venous Malformations: A Systematic Review
30天前
已完结
Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: preliminary pharmacokinetics and pharmacodynamic data
30天前
已完结